Genetic Testing

NCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics’ Prolaris® Test as an ‘Advanced Tool’ Recommended for Prognostic AssessmentNCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics’ Prolaris® Test as an ‘Advanced Tool’ Recommended for Prognostic Assessment

NCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics’ Prolaris® Test as an ‘Advanced Tool’ Recommended for Prognostic Assessment

Prolaris Remains a Long-Standing Fixture in the Guidelines for 10th Year RunningSALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) --…

6 months ago
Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of  LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson’s DiseaseDenali Therapeutics Announces First Participant Dosed in Phase 2a Study of  LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson’s Disease

Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson’s Disease

SOUTH SAN FRANCISCO, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced initiation of dosing…

6 months ago
My Compounding of Brisbane Now Offers Compounding Services Across AustraliaMy Compounding of Brisbane Now Offers Compounding Services Across Australia

My Compounding of Brisbane Now Offers Compounding Services Across Australia

BRISBANE, AUSTRALIA / ACCESSWIRE / November 26, 2024 / The healthcare landscape in Australia has taken a significant stride forward…

6 months ago
CMTA and INC Forge Groundbreaking Alliance to Accelerate Comprehensive Research Across All Charcot-Marie-Tooth Disease TypesCMTA and INC Forge Groundbreaking Alliance to Accelerate Comprehensive Research Across All Charcot-Marie-Tooth Disease Types

CMTA and INC Forge Groundbreaking Alliance to Accelerate Comprehensive Research Across All Charcot-Marie-Tooth Disease Types

CMTA strengthens its role as the leading force in comprehensive CMT research, forging a new strategic alliance with the Inherited…

7 months ago
Frontage Laboratories and Medicover Integrated Clinical Services Announce Strategic Collaboration to Expand Global Genomic Testing ServicesFrontage Laboratories and Medicover Integrated Clinical Services Announce Strategic Collaboration to Expand Global Genomic Testing Services

Frontage Laboratories and Medicover Integrated Clinical Services Announce Strategic Collaboration to Expand Global Genomic Testing Services

EXTON, PA / ACCESSWIRE / November 12, 2024 / Frontage Laboratories, Inc., a global CRO, and Medicover Integrated Clinical Services…

7 months ago
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor ConferencesRhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming…

7 months ago
Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic TestingMyriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing

Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing

SALT LAKE CITY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and…

7 months ago
3X4 Genetics and Rupa Health Partnership Aims to Bridge the Gap Between Genetic Science and Clinical Practice3X4 Genetics and Rupa Health Partnership Aims to Bridge the Gap Between Genetic Science and Clinical Practice

3X4 Genetics and Rupa Health Partnership Aims to Bridge the Gap Between Genetic Science and Clinical Practice

SEATTLE, Oct. 31, 2024 /PRNewswire/ -- 3X4 Genetics, a global leader in genetic testing, is proud to announce an exciting…

7 months ago